|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$4,069
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$339,315
|
$339,315
|
Barchi, Joseph
|
CCR (NCI)
|
|
A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC
|
ZIA BC 011786
|
$32,548
|
$32,548
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$97,645
|
$97,645
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$76,612
|
Barr, Frederic
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,497,944
|
$724,898
|
Custer, Mary
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$37,792
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$362,249
|
$253,575
|
Buck, Christopher
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$357,695
|
$357,695
|
Apolo, Andrea
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,562,883
|
$156,288
|
Restifo, Nicholas
|
CCR (NCI)
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$498,365
|
$49,836
|
Garfield, Susan
|
CCR (NCI)
|
|
CCR Genomics Core
|
ZIC BC 011623
|
$850,744
|
$85,074
|
Conner, Elizabeth
|
CCR (NCI)
|
|
Characterization of Biological Nanoparticle Subsets
|
ZIA BC 011502
|
$248,748
|
$12,437
|
Jones, Jennifer
|
CCR (NCI)
|
|
Clinical Fellowship Training Program
|
ZIE BC 011023
|
$318,550
|
$159,275
|
Pinto, Peter
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$766,596
|
$498,287
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$511,064
|
$383,298
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Comparison of molecular factors to drug activities
|
ZIC BC 011509
|
$102,120
|
$10,212
|
Reinhold, William
|
CCR (NCI)
|
|
Consequences of chronic Interferon-gamma expression on the host
|
ZIA BC 009283
|
$1,020,013
|
$102,001
|
Young, Howard
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$897,044
|
$179,409
|
Meier, Jordan
|
CCR (NCI)
|
|
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
|
ZID BC 011792
|
$418,466
|
$41,847
|
Pack, Svetlana
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$312,747
|
$93,824
|
Beutler, John
|
CCR (NCI)
|
|
Dysregulation of Antigen Presenting Cell Function in Cancer
|
ZIA BC 011687
|
$252,002
|
$252,002
|
Roche, Paul
|
CCR (NCI)
|
|
Evaluation of Protein Kinase D1 in Bladder Cancer as a possible oncogene
|
ZIA BC 011592
|
$130,193
|
$130,193
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Experimental Pathology Laboratory (EPL)
|
ZIC BC 011638
|
$1,402,891
|
$140,289
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$246,303
|
$24,630
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
|
ZIA BC 011337
|
$677,728
|
$203,318
|
Yang, James
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$587,732
|
$35,264
|
Gottesman, Michael
|
CCR (NCI)
|
|
Genetics of Complex Diseases and Health Disparities
|
ZIA BC 010022
|
$469,536
|
$469,536
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Genomics and Bioinformatics Group web site development and maintenance
|
ZIC BC 011475
|
$178,709
|
$35,742
|
Reinhold, William
|
CCR (NCI)
|
|
Growth-Differentiation Factors in Organogenesis
|
ZIA BC 005093
|
$748,932
|
$674,039
|
Perantoni, Alan
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$32,548
|
$32,548
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,344,149
|
$67,207
|
Chinquee, Joseph
|
CCR (NCI)
|
|
Hypoxia and Tyrosine Kinase Signaling Integration in Urologic Cancers
|
ZIA BC 011095
|
$191,882
|
$191,882
|
Bottaro, Donald
|
CCR (NCI)
|
|
Identification of Genetic Factors Associated with Infectious Diseases
|
ZIA BC 010297
|
$313,024
|
$125,210
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$511,155
|
$25,558
|
Khan, Javed
|
CCR (NCI)
|
|
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
|
ZIB BC 010906
|
$1,947,268
|
$778,907
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Investigation of Epigenetic Modifiers in Bladder Cancer
|
ZIA BC 011593
|
$32,548
|
$32,548
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Mechanisms of Immune-mediated Tumor Cell Destruction
|
ZIA BC 010012
|
$218,360
|
$87,344
|
Sayers, Thomas
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$1,007,541
|
$50,377
|
Gottesman, Michael
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,201,344
|
$630,202
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Metabolic characterization of FH- and SDH-deficient RCC cell lines
|
ZIA BC 011701
|
$117,540
|
$117,540
|
Moscow, Jeffrey
|
CCR (NCI)
|
|
microRNA Profiling in the Spectrum of Kidney Tumors
|
ZIA BC 011405
|
$128,088
|
$128,088
|
Merino, Maria
|
CCR (NCI)
|
|
Molecular biology of human polyomaviruses
|
ZIA BC 011090
|
$362,249
|
$181,125
|
Buck, Christopher
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$905,521
|
$362,209
|
Hou, Steven
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$58,595
|
$29,297
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$2,317,028
|
$463,406
|
Edelman, Daniel
|
CCR (NCI)
|
|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIA BC 011458
|
$195,289
|
$195,289
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$1,022,127
|
$1,011,906
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,022,127
|
$766,596
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$356,352
|
$178,176
|
Bottaro, Donald
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $17,681,275
|